The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 339:1158-1160 October 15, 1998 Number 16
NextNext

Prevention and Medicare Costs

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Daviglus, M. L.
-PubMed Citation
Once viewed as an inevitable consequence of aging, cardiovascular disease is now known to be related to modifiable risk factors, especially smoking, elevated blood pressure, and elevated cholesterol. Numerous preventive interventions have been developed in recent decades to combat these risk factors. The issue now is how best to allocate resources among these interventions in order to prevent disease.

Antihypertensive drugs, for example, though effective, vary widely in their cost effectiveness. Propranolol costs $20,000 to save a year of life (life-year) for adults 35 to 64 years of age, and captopril costs $130,0001 (the medical component of the Consumer Price . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.